Germany· DE-A57-0c221e6c24b8596a

Voxsio

A medicinal product containing levoleucovorin, registered in Germany by Infectopharm Arzneimittel Und Consilium Gmbh, De, Heppenheim.

Checked against EMA Article 57 (European Union) on September 30, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about levoleucovorinAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

The record

At a glance

EMA Article 57 (European Union)

Active substance: Levoleucovorin
Manufacturer: Infectopharm Arzneimittel Und Consilium Gmbh, De, Heppenheim
Country: Germany (DE)
ATC code: —
Reimbursed: Not published by this register
Source register: EMA Article 57 (European Union)
Last checked: September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Levoleucovorin in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All levoleucovorin products

Authorised across Europe · EMA

The same active substance is authorised in 17 EEA countries. Names it is sold under:

Austria · Voxsio
Belgium · Elvorine, Levofolic
Estonia · Levofolinic Acid Medac
Spain · Isovorin
Finland · Levofolic
France · Elvorine, Levofolinate De Calcium Zentiva
United Kingdom (Northern Ireland) · Levofolinic Acid Medac
Greece · Folivoran
Italy · Calcio Levofolinato Teva Generics, Folanemin
Lithuania · Levofolino Rugštis Medac
Luxembourg · Elvorine
Latvia · Levofolic
Poland · Levofolic
Portugal · Levofolic, Levofolinato De Cálcio Farmoz
Sweden · Natriumlevofolinat Medac
Slovenia · Levofolic
Slovakia · Levofolic

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/bf603d40-eef1-44c7-93de-ab8ae5f125e8
GET /v1/drugs/bf603d40-eef1-44c7-93de-ab8ae5f125e8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Oral Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Levoleucovorin",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}

API reference MCP server Plans

See everything about levoleucovorin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console